CTLA4 Methylation and its Expression as a Prognostic Biomarker in Tobacco Users with and without Oral Squamous Cell Carcinoma- A Protocol for Cross-sectional Study by Prajakta R Zade, Minal S Chaudhary, Muhil V Seralathan, Alka H Hande, Madhuri N Gawande

Subjects: Get full text

Cytotoxic T-lymphocyte-associated 4 protein expression is associated with a high international prognostic score in advanced-stage classical Hodgkin lymphoma by Flora Dameria Pangaribuan, Maria Francisca Ham, Mutiah Mutmainnah, Agnes Stephanie Harahap

Subjects: Get full text

Association of Polymorphisms in T-Cell Activation Costimulatory/Inhibitory Signal Genes With Allograft Kidney Rejection Risk by Jose Luis Santiago, Jose Luis Santiago, Luis Sánchez-Pérez, Isabel Pérez-Flores, Maria Angeles Moreno de la Higuera, Natividad Calvo Romero, Javier Querol-García, Elena Urcelay, Ana Isabel Sánchez-Fructuoso

Subjects: Get full text

Cytotoxic T-Lymphocyte-Associated Protein 4 Haploinsufficiency-Associated Inflammation Can Occur Independently of T-Cell Hyperproliferation by Carole Le Coz, Brian E. Nolan, Melissa Trofa, Alicia M. Kamsheh, Mustafa K. Khokha, Mustafa K. Khokha, Mustafa K. Khokha, Saquib A. Lakhani, Saquib A. Lakhani, Antonio Novelli, Elaine H. Zackai, Elaine H. Zackai, Kathleen E. Sullivan, Kathleen E. Sullivan, Silvana Briuglia, Tricia R. Bhatti, Tricia R. Bhatti, Neil Romberg, Neil Romberg

Subjects: “…cytotoxic T-lymphocyte-associated protein 4…”
Get full text

Ultraviolet Radiation and Melanomagenesis: From Mechanism to Immunotherapy by Xiaoying Sun, Xiaoying Sun, Na Zhang, Chengqian Yin, Bo Zhu, Xin Li, Xin Li

Subjects: Get full text

Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer by Christine Joy I. Bulaon, Christine Joy I. Bulaon, Christine Joy I. Bulaon, Narach Khorattanakulchai, Kaewta Rattanapisit, Hongyan Sun, Nuttapat Pisuttinusart, Nuttapat Pisuttinusart, Nuttapat Pisuttinusart, Richard Strasser, Shiho Tanaka, Patrick Soon-Shiong, Waranyoo Phoolcharoen, Waranyoo Phoolcharoen

Subjects: “…cytotoxic T lymphocyte-associated protein 4…”
Get full text

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates by Shun Kawashima, Kole Joachim, Maen Abdelrahim, Ala Abudayyeh, Kenar D. Jhaveri, Naoka Murakami

Subjects: “…immune checkpoint inhibitor; transplantation; graft rejection; programmed cell death protein 1; cytotoxic t-lymphocyte-associated protein 4…”
Get full text

Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression by Hayana Ramos Lima, Thaís Helena Gasparoto, Tatiana Salles de Souza Malaspina, Vinícius Rizzo Marques, Marina Jurado Vicente, Elaine Camarinha Marcos, Fabiana Corvolo Souza, Maria Renata Sales Nogueira, Jaison Antônio Barreto, Gustavo Pompermaier Garlet, João Santana da Silva, Vânia Nieto Brito-de-Souza, Ana Paula Campanelli

Subjects: Get full text

The functions of Th17/Treg cells and relevant studies on the treatment of periodontitis and atherosclerosis by ZHANG Yaoyue, LIN Xiaoping

Subjects: Get full text

A functional antibody cross-reactive to both human and murine cytotoxic T-lymphocyte-associated protein 4 via binding to an N-glycosylation epitope by Dong Li, Jing Li, Huanyu Chu, Zhuozhi Wang

Subjects: “…Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)…”
Get full text

Decreased T helper 17 cells in tuberculosis is associated with increased percentages of programmed death ligand 1, T helper 2 and regulatory T cells by Chin-Chung Shu, Ming-Fang Wu, Jann-Yuan Wang, Hsin-Chih Lai, Li-Na Lee, Bor-Luen Chiang, Chong-Jen Yu

Subjects: Get full text

Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-... by Takuma Imakita, Kohei Fujita, Takanori Ito, Zentaro Saito, Issei Oi, Osamu Kanai, Hiromasa Tachibana, Satoru Sawai, Tadashi Mio

Subjects: “…Cytotoxic T-lymphocyte-associated protein-4…”
Get full text

Risk of Gastrointestinal Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Systematic Review and Meta-Analysis by Wenhan Yang, Wenhan Yang, Peng Men, Huimin Xue, Mingyan Jiang, Mingyan Jiang, Qiuhua Luo, Qiuhua Luo

Subjects: Get full text

Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients by Li Xu, Li Xu, Xin Yan, Weiyue Ding, Weiyue Ding

Subjects: Get full text

Multifocal gastric adenocarcinoma in a patient with LRBA deficiency by Nina Bratanič, Jernej Kovač, Katka Pohar, Katarina Trebušak Podkrajšek, Alojz Ihan, Tadej Battelino, Magdalena Avbelj Stefanija

Subjects: Get full text

Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review by Walid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, Amjad Abu Salman, Ashraf Abu Jama, Sondos Shalata, Kais Halumi, Alexander Yakobson

Subjects: Get full text

B Cell Subsets and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia by Aviwe Ntsethe, Zekhethelo Alondwe Mkhwanazi, Phiwayinkosi Vusi Dludla, Bongani Brian Nkambule

Subjects: Get full text

Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report by Ayumu Takeno, Masahiro Yamamoto, Miwa Morita, Sayuri Tanaka, Ippei Kanazawa, Mika Yamauchi, Sakae Kaneko, Toshitsugu Sugimoto

Subjects: “…Anti-cytotoxic T-lymphocyte-associated protein 4 antibody…”
Get full text

Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy by Pooya Farhangnia, Pooya Farhangnia, Shamim Mollazadeh Ghomi, Mahzad Akbarpour, Mahzad Akbarpour, Ali-Akbar Delbandi, Ali-Akbar Delbandi, Ali-Akbar Delbandi

Subjects: “…CTLA-4 (cytotoxic T lymphocyte-associated protein 4)…”
Get full text

Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint Inhibitors by Ai-Tram N. Bui, Kevin Tyan, Anita Giobbie-Hurder, Isaac A. Klein, Michael P. Manos, Leyre Zubiri, Kerry Reynolds, Shilpa Grover, Gerald L. Weinhouse, Patrick A. Ott, Nicole R. LeBoeuf, Osama Rahma

Subjects: Get full text